Navigation Links
End in Biological Technology

Mylan Again Calls for an End to Authorized Generics During 180-Day Exclusivity Period

Sees opportunity to end abusive use of authorized generics during period of exclusivity PITTSBURGH, June 3 /PRNewswire-FirstCall/ -- Mylan Inc.'s (Nasdaq: MYL ) Chief Operating Officer Heather Bresch today testified before the U.S. House of Representatives Judiciary Subcommittee on Courts a...

ChromaDex Announces 2008 Year End Financial Results

IRVINE, Calif., April 3 /PRNewswire-FirstCall/ -- ChromaDex Corporation, (OTC Bulletin Board: CDXC) a leader in phytochemical reference standards and contract research, today announced financial results for the 2008 Fiscal Year. On a reported basis calculated in accordance with U.S. Generally Acce...

International Isotopes Inc. Announces Year End Financial Results

Company Shows a 19% Increase In Total Revenue To $5.6 Million; 34% Increase in Gross Profit IDAHO FALLS, Idaho, March 27 /PRNewswire-FirstCall/ -- International Isotopes Inc. (OTC Bulletin Board: INIS) announces the financial results for fiscal year ended December 31, 2008. Total Re...

BioMS Medical Announces 2008 Year End Results

Toronto Stock Exchange Symbol: MS EDMONTON, March 17 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced financial and operational results for the year ended December 31, 2008. "Dirucotide has demonstrated ...

AutoImmune Inc. Reports 2008 Fourth Quarter and Year End Financial Results

PASADENA, Calif., March 16 /PRNewswire-FirstCall/ -- AutoImmune Inc. (OTC Bulletin Board: AIMM) today reported a net loss of $129,000, or $0.01 per share basic and diluted, for the three months ended December 31, 2008, compared with a net loss of $56,000, or break even per share basic and diluted,...

Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results

Net operating expenses decreased by 33% in 2008; Forecast cutting net operating expenses by approximately 50% in 2009 CTI expects to complete pixantrone NDA submission in Q2 2009 SEATTLE, March 16 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) today repo...

Dendreon Reports Fourth Quarter and 2008 Year End Financial Results

SEATTLE, March 12 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN ) today reported results for the year and quarter ended December 31, 2008. Revenues for the year ended December 31, 2008 were $111,000 compared to $743,000 for the year ended December 31, 2007. Revenues for the fourth...

Interleukin Genetics Reports Fourth Quarter and Year End 2008 Financial Results

WALTHAM, Mass., March 9 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE: Alternext US: ILI) today announced financial and operational results for the fourth quarter and year ended December 31, 2008. "In 2008, we put an experienced staff in place to establish the Company as a ma...

Oncothyreon announces webcast of fourth quarter and year end 2008 financial results conference call

SEATTLE, March 3 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) (TSX:ONY), a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it intends to release its fourth quarter and year end 2008 financial ...

Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting

KVISTGAARD, Denmark, March 3 /PRNewswire-FirstCall/ -- Following the completion of the Phase II clinical development of IMVAMUNE(R), a third-generation smallpox vaccine, Bavarian Nordic has held an end of Phase II meeting with the FDA to discuss the Phase III development. The meeting was a suc...

Psychemedics Corporation Announces 2008 Year End Results

Declares Quarterly Dividend ACTON, Mass., Feb. 18 /PRNewswire-FirstCall/ -- Psychemedics Corporation (Nasdaq: PMD ) today announced fourth quarter and year-end financial results for the period ended December 31, 2008. The Company also announced a quarterly dividend of $0.17 per share payab...

Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results

CAMBRIDGE, Mass., Feb. 17 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today reported unaudited financial results for the fourt...

BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update

BIRMINGHAM, Ala., Feb. 6 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) today announced financial results for the fourth quarter and year ended December 31, 2008. Fourth Quarter 2008 Financial Results For the three months ended December 31, 2008, the Compan...

GlaxoSmithKline Reports Q4 and Year End Results 2008

LONDON, February 5 /PRNewswire-FirstCall/ -- In a video interview Andrew Witty, GlaxoSmithKline CEO, described the pharmaceutical group's results as "robust" in a year that was "always going to be challenging". GSK also announced that it will cease providing EPS guidance, to allow a foc...

CryoLife Announces Release Date and Teleconference Call Details for 2008 Fourth Quarter and Year End Financial Results

ATLANTA, Feb. 5 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY ), a biomaterials, medical device and tissue processing company, announced today that 2008 fourth quarter and year end financial results will be released on Thursday, February 19, 2009. The Company will hold a teleconference ca...

Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date

CRANBURY, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD ) will announce fourth quarter and full year 2008 financial results after the regular close of markets on Thursday, February 5, 2009. The results announcement will be followed by a live conference call and webcas...

Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2008 Financial Results

Conference Call and Webcast Scheduled for Tuesday, February 3, 2009 SAN DIEGO, Jan. 27 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that the Company will report its fourth quarter and year-end 2008 financial results after the Nasdaq market closes o...

OmniComm Systems, Inc. Experiences Record Year End Results - $18 Million in Signed Contracts for the Year 2008

FT. LAUDERDALE, Fla., Jan. 16 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), a leader in integrated electronic data capture solutions for clinical trials, today announced record breaking results for 2008 in new and repeat business that exceeded original expectatio...

NPL research shows there could be no end in sight for Moore’s Law

The fast pace of growing computing power could be sustained for many years to come thanks to new research from the UK's National Physical Laboratory (NPL) that is applying advanced techniques to magnetic semiconductors. Moore's Law observed that the density of transistors on an integrated circ...

The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance

CHICAGO, Dec. 1 /PRNewswire-FirstCall/ -- The Female Health Company (Amex: FHC ), which manufactures and markets the FC Female Condom(R), today reported record operating results for the quarter and fiscal year ended September 30, 2008. For the three months ended September 30, 2008, net r...

Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results

LEXINGTON, Mass., Nov. 25 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ) today announced its consolidated results of operations for the fiscal year and the three-month period ended September 30, 2008. The Company will host a conference call and webcast today beginning a...

Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14%

ANTONY, France, October 15 /PRNewswire-FirstCall/ -- (EUR millions) 2007 07/06 2008 08/07 EUR % % EUR % % millions sales change millions sales change Southern Europe (...

PURE Bioscience Reports Fourth Quarter and Year End Results

SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- PURE Bioscience (Nasdaq: PURE), creators of the patented antimicrobial, silver dihydrogen citrate (SDC), today reported revenues for the fiscal year ended July 31, 2008 of $1,487,500, which increased more than 340% compared with $336,400 in the prio...

Neurobiological Technologies Announces Dates for 2008 Fiscal Year End Financial Results Conference Call and Presentation at MCF Investor Summit

EMERYVILLE, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: NTII ), today announced it will release its fiscal 2008 fourth quarter and year-end financial results on September 16, 2008. The Company will also host a call to discuss its financial...

ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008

RANCHO CORDOVA, Calif., Sept. 3 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL ), a leading supplier of innovative products that process and store adult stem cells, announced today it will report financial results for the fourth quarter and full year ended June 30, 2008, on Tuesd...

Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results

-- Company provides revenue guidance and strategic plan 2009/ 2010 -- LAVAL, QC, Aug. 28 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) today reported its financial results for the fourth quarter and year ended May 31, 2008. The Compa...

Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008

28 New Contracts Valued at $115.5 Million Signed in Fourth Quarter SUNNYVALE, Calif., Aug. 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today financial results for the fourth quarter and fiscal year ended June 28...

AST Endorses Istanbul Declaration to End Organ Trafficking and Transplant Tourism

American Society of Transplantation Admonishes Citizens of Rich Nations To End Reliance on Donors in Less Affluent Nations MT. LAUREL, N.J., Aug. 19 /PRNewswire/ -- The American Society of Transplantation (AST) endorses The Declaration of Istanbul on Organ Trafficking and Transplant ...

Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results

BETHESDA, Md., June 12 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX ), an independent American provider of international healthcare services and Western healthcare products in the People's Republic of China, today announced results for its fiscal year end and fourth quarte...

Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Fourth Quarter and Year End Results on Thursday, June 12, 2008

BETHESDA, Md., May 13 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX ) a leading independent American provider of Western healthcare products and services in the People's Republic of China, announced that it intends to release its financial results for the fourth quarter end...

Genmab Announces Year End 2007 Financial Results

Genmab Reports Financial Results for the 12 Months Ended December 31, 2007 COPENHAGEN, Denmark, March 31 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today results for the financial year ended December 31, 2007. Revenues of DKK 530 million (approximately USD 104 million) compared...

China Pharma Holdings, Inc. Announces Record 2007 Year End Results

-- Fiscal year Revenue Increased 51.9% to $33.2 Million -- Fiscal year Net Income Increased 49.3% to $12.8 Million -- The Company Provides Guidance of 40% Growth in Revenue for 2008 NEW YORK and HAIKOU, Hainan, China, March 31 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Ho...

GeneNews announces 2007 year end results

TORONTO, March 26 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today reported operational and financial results for the fourth quarter and year ended Dec...

Interleukin Genetics Announces Conference Call and Webcast to Discuss Fourth Quarter and Year End 2007 Business Results

WALTHAM, Mass., March 20 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI ), announced today that it will host a conference call and webcast on Thursday, March 27, 2008 at 4:30 p.m. EDT to review the Company's fourth quarter and year end 2007 financial results and provide an up...

BioMS Medical Announces 2007 Year End Results

Toronto Stock Exchange Symbol: MS EDMONTON, March 18 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis ("MS"), today announced financial and operational results for the year ended December 31, 2007. "We conti...

Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results

Conference Call/Webcast to be Held Wednesday, March 19 at 10:00 AM EDT CEDAR KNOLLS, N.J., March 17 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS ) today announced its financial results for the fourth quarter and year ended December 31, 2007. Emisphere will host a co...

AutoImmune Inc. Reports 2007 Fourth Quarter and Year End Financial Results

PASADENA, Calif., March 14 /PRNewswire-FirstCall/ -- AutoImmune Inc. (OTC Bulletin Board: AIMM) today reported a net loss of $56,000, or break even per share basic and diluted, for the three months ended December 31, 2007, compared with a net profit of $36,000, or break even per share basic an...

Emisphere Technologies, Inc. Announces Conference Call for 2007 Fourth Quarter and Year End Financial Results

Conference Call/Webcast to be Wednesday, March 19 at 10:00 AM EDT CEDAR KNOLLS, N.J., March 14 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS ) will host a conference call discussing its financial results for the fourth quarter and year ended December 31, 2007 on Wedn...

Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results

- Pipeline Update Conference Call and Webcast on March 14 at 8:00 a.m. PDT - SAN DIEGO, March 13 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO ), a biopharmaceutical company developing and commercializing products targeting the extracellu...

Dendreon Reports Fourth Quarter and 2007 Year End Financial Results

- Dendreon to Hold Conference Call Today, March 13, 2008 at 11:00 AM ET - SEATTLE, March 13 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN ) today reported results for the year and quarter ended December 31, 2007. Revenues for the year ended December 31, 2007 were $743,000 compar...
Other Tags
(Date:8/28/2014)... (August 28, 2014) Researchers at the University of ... muscular dystrophy (FSHD) to be used for muscle regeneration ... potential therapies for FSHD. , The research is published ... Reports . , There is no treatment for FSHD, ... common type of muscular dystrophy. FSHD is an unusual ...
(Date:8/28/2014)... delivering compounds that could positively impact the ... be possible, thanks to researchers in Penn ... vaginal suppository made from the seaweed-derived food ... drug Tenofovir provides a woman-initiated, drug-delivery vehicle ... sexually transmitted infections during unprotected heterosexual intercourse, ...
(Date:8/28/2014)... of new roads will be built worldwide by 2050. ... wildernesses, where they bring an influx of destructive loggers, ... study has created a ,global roadmap, for prioritising road ... competing demands of development and environmental protection. , The ... that natural importance of ecosystems and a ,road-benefits, layer ...
Breaking Biology News(10 mins):UMN researchers find animal model for understudied type of muscular dystrophy 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 3Study shows where on the planet new roads should and should not go 2Study shows where on the planet new roads should and should not go 3
(Date:8/29/2014)... 29, 2014 Sansego is ... an interactive online community, and a range of personalized ... all the way to professional athletes. Crowie has brought ... been with him throughout the majority of his triathlon ... in the triathlon public. , Sansego provides the following:, ...
(Date:8/29/2014)... College of Social Work is the recipient of a ... National Institute of Drug Abuse (NIDA) at the National Institutes ... consequences of heroin use. Additionally, the grant provides resources to ... , Heroin use has increased steadily since 2007 according ... to the cheaper and more available opioid. , A ...
(Date:8/29/2014)... Ethane Web Technologies, an ISO 9001:2008 ... service named HTML web design. , The HTML web ... the service, Ethane Web Technologies did extensive research about ... has done its best efforts to make sure that ... outstanding results to clients. The company uses all ...
(Date:8/29/2014)... 2014: New ESC registries are being launched on ... announcement comes as the long-term phase of the ... heart failure patients conducted in collaboration with the ... an outcomes evaluation. , The registries are all ... , Professor Roberto Ferrari, Chairperson of EORP, said: ...
(Date:8/29/2014)... Thompson HealthDay Reporter , THURSDAY, ... the early days of the Ebola outbreak in West Africa ... and spreads. Researchers report in the Aug. 28 online ... the following: The Ebola strains responsible for the ... the very first recorded outbreak of Ebola in central Africa ...
Breaking Medicine News(10 mins):Health News:5 x World Champion Triathlete, Craig “Crowie” Alexander, Launches Online Triathlon Coaching Company – Sansego 2Health News:5 x World Champion Triathlete, Craig “Crowie” Alexander, Launches Online Triathlon Coaching Company – Sansego 3Health News:$1.25 million NIH grant to aid research on impact of heroin use 2Health News:Ethane Web Technologies Launches a New Web Design Service 2Health News:New ESC registries launched on cardiac oncology and ACS 2Health News:New ESC registries launched on cardiac oncology and ACS 3Health News:New ESC registries launched on cardiac oncology and ACS 4Health News:Gene Research Yields Insights Into Ebola Virus 2Health News:Gene Research Yields Insights Into Ebola Virus 3
Other Contents